(Q39215504)
Statements
Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia (English)
Katherine S Panageas
Nicole Lamanna
Matt Kalaycio
Joseph G Jurcic
Mark Heaney
Renier Brentjens
Denise Horgan
Alison Gencarelli
David A Scheinberg